ApiFix

ApiFix is developing a truly breakthrough minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis (AIS).

The ApiFix Opportunity

  • Game-changing technology: Minimally invasive solution that addresses limitations of invasive surgery; strong patent protection
  • Cost-saving solution: Saves ~45% total costs (OR and hospitalization); reduces need for revision surgery
  • Large market: $900 million worldwide addressable market
  • Strong clinical evidence: CE approved, FDA in process; sales in much of Europe (including Germany, Italy, and Spain); successful trials on 145 patients in 7 countries

The Product

The minimally invasive ApiFix system incorporates a miniature ratchet mechanism that captures incremental corrections performed by the patient according to the physical therapy regimen. The deformity correction process spans several months to allow the soft tissues to accommodate any minor correction. The ApiFix system is inserted through a small incision in the patient’s back and uses only two screws to support its ratchet-based, small expandable rod.

The ApiFix Procedure vs. Current Procedure

  • Significantly smaller incision: ~10 centimeters vs. standard ~45 centimeters
  • Shorter surgery time: ~1 hour vs. 4-6 hours
  • Reduced length of stay (hospitalization): 2-3 days vs. 6-7 days

The Team

ApiFix CEO Eran Feldhay, M.D.

ApiFix CEO Eran Feldhay, M.D.

  • Eran Feldhay, CEO: More than 16 years of management experience in medical devices, health care IT, and early-stage medical technology start-ups
  • Uri Arnin, Founder & CTO: More than 10 years of experience in the spine field; inventor and CTO, Impliant Inc.; founder and CTO, Spine21 Ltd.
  • Prof. Yizhar Floman, M.D., Founder: Spine surgeon; president of the Israeli Spine Society

 

Status & Achievements

The ApiFix system has been used on 166 patients (as of 30 September 2017).

Founded: 2011
Stage: Revenue (commercial sales in 9 countries); 5 distribution agreements (Canada, Spain, Holland, Greece, Singapore)
Investors: The Trendlines Group, B. Braun
IP: 7 families of granted and pending patents
Certification:
CE mark
Awards:
2016, National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Competition Winner
2012, Best Start-Up, Israel’s Office of the Chief Scientist of the Ministry of Economy

In the Media

The Background & Market

Today’s gold standard for correcting spinal deformities involves fusing an average of 10 motion levels using a large number of screws in a surgical procedure that lasts an average of six hours and costs upward of $100,000. There are approximately 80,000 surgeries to repair spinal deformities performed annually worldwide. The cost of scoliosis correction implants in the United States, not including hospitalization, is around $600 million annually, with an estimated $300 million market outside the United States.

Media


Founder Dr. Yizhar Floman on ILTV


Founder Uri Arnin presents ApiFix


ApiFix animation

ApiFix ratchet system for scoliosis treatment
The ApiFix scoliosis treatment system

Contact

Eran Feldhay, M.D., CEO
+972.72.260.7068
eran@apifix.com
www.apifix.com
icon_Face-gray icon_Twitter-gray

 

Logo-ApiFix

Font Resize
Contrast